Kausch W
Rontgenblatter. 1981 Mar;34(3):91-3.
The introduction of the non-ionogenic product metrizamide made lumbosacral myelography a low-risk, invasive diagnostic procedure. Examination carried out on an outpatient basis does not involve greater risks or side effects than examination on an inpatient basis. However, it is essential that--apart from informing the patient properly--the patient shows discipline and remains available for the examining physician during a period of 36 hours.
非离子型产品甲泛葡胺的引入使腰骶部脊髓造影成为一种低风险的侵入性诊断程序。门诊进行的检查与住院检查相比，风险和副作用并不会更大。然而，至关重要的是，除了适当地告知患者外，患者要遵守规定，并在36小时内随时可供检查医生检查。
